Brain Health Program for Older Adults With Subjective Cognitive Decline

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05934136
Collaborator
(none)
50
2
26

Study Details

Study Description

Brief Summary

The investigators will compare two brain health programs in older adults with subjective cognitive decline and lifestyle risk factors for dementia. The primary aim of the study is to determine the credibility, expectancy, feasibility, acceptability, appropriateness, fidelity, and satisfaction of the programs.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: My Healthy Brain 1
  • Behavioral: My Healthy Brain 2
N/A

Detailed Description

The investigators aim to promote brain health by reducing lifestyle risk factors for dementia in older adults with subjective cognitive decline (SCD). This study is a pilot randomized control trial (RCT) comparing two virtual lifestyle programs, My Healthy Brain 1 and My Healthy Brain 2. Eligible older adults include: age ≥ 60, self-reported worry about changes in memory or thinking, and risk factors for dementia (determined by the Cardiovascular Risk Factors, Aging, and Incidence of Dementia score ≥ 6). Participants will be randomized to one of two groups (My Healthy Brain 1 or My Healthy Brain 2) and will complete 8 weekly 90-minute sessions via Zoom delivered by a clinical psychologist. Each session will focus on a different topic relevant to brain health (e.g. physical activity, sleep, etc.). The primary aim of the study is to determine the credibility, expectancy, feasibility, acceptability, appropriateness, fidelity, and satisfaction of the programs. The investigators will also explore improvements in cognition, lifestyle behaviors (physical activity, sleep, nutrition, alcohol and tobacco use, social functioning), depression, anxiety, and mindfulness assessed at baseline, post-intervention, and 6 month follow-up. All participants will wear a watch to monitor changes in lifestyle during the program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
My Healthy Brain: A Group-Based Lifestyle Intervention to Modify Early Risk of Dementia in Older Adults
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Nov 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: My Healthy Brain 1

My Healthy Brain 1 is an 8-week group program delivered via 90-minute Zoom meetings led by a clinical psychologist. It provides education on the link between dementia and lifestyle factors, including poor exercise, sleep, diet/nutrition, mental and social stimulation, alcohol, and smoking. My Healthy Brain 1 participants learn evidence-based mindfulness and behavior change skills to address common barriers to healthy habits, such as stress and setting achievable goals. My Healthy Brain 1 participants wear an activity watch to monitor lifestyle changes during the program.

Behavioral: My Healthy Brain 1
My Healthy Brain 1 is an 8-week group program delivered via 90-minute Zoom meetings led by a clinical psychologist. It provides education on the link between dementia and lifestyle factors, including poor exercise, sleep, diet/nutrition, mental and social stimulation, alcohol, and smoking. My Healthy Brain 1 participants learn evidence-based mindfulness and behavior change skills to address common barriers to healthy habits, such as stress and setting achievable goals. My Healthy Brain 1 participants wear an activity watch to monitor lifestyle changes during the program.

Active Comparator: My Healthy Brain 2

My Healthy Brain 2 condition controls for the effect of time spent and support/feedback from the group and interventionist. Participants in My Healthy Brain 2 will receive education on lifestyle, brain health, and cognitive decline symptoms in addition to usual care as determined by their medical team. Each weekly session will focus on a different topic: 1) lifestyle and brain health, 2) physical activity, 3) sleep, 4) nutrition, 5) medical adherence, 6) cognitive health, 7) social support, and 8) a program overview. My Healthy Brain 2 is conducted in the same format as My Healthy Brain 1 (8 weekly Zoom sessions, 90 minutes each), but does not include behavior change strategies. My Healthy Brain 2 participants wear an activity watch to monitor lifestyle changes during the program.

Behavioral: My Healthy Brain 2
My Healthy Brain 2 condition controls for the effect of time spent and support/feedback from the group and interventionist. Participants in My Healthy Brain 2 will receive education on lifestyle, brain health, and cognitive decline symptoms in addition to usual care as determined by their medical team. Each weekly session will focus on a different topic: 1) lifestyle and brain health, 2) physical activity, 3) sleep, 4) nutrition, 5) medical adherence, 6) cognitive health, 7) social support, and 8) a program overview. My Healthy Brain 2 is conducted in the same format as My Healthy Brain 1 (8 weekly Zoom sessions, 90 minutes each), but does not include behavior change strategies. My Healthy Brain 2 participants wear an activity watch to monitor lifestyle changes during the program.

Outcome Measures

Primary Outcome Measures

  1. Credibility and Expectancy Questionnaire [0 Weeks]

    Assesses how believable, convincing, and logical patients perceive the treatment to be. Higher scores (min = 3, max = 27) scores indicate greater credibility and expectancy.

  2. Client Satisfaction Questionnaire [8 Weeks]

    Assesses patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction.

  3. Rates of Recruitment and Enrollment [0 Weeks]

    We will assess the feasibility of recruiting and enrolling participants into the study by calculating the proportion who agree to participate divided by the total number contacted (≥70% good, ≥ 80% excellent).

  4. Rates of Missing Outcomes Data [8 Weeks]

    We will assess the feasibility of data collection by calculating the proportion of secondary outcomes (cognition and lifestyle) with no missing data divided by the total number collected (≥70% good, ≥ 80% excellent).

  5. Rates of Valid Activity Watch Data (7 or more hours of wear time) [8 Weeks]

    We will assess the feasibility of collecting valid activity watch data by calculating the proportion of valid days (7 or more hours of wear time) divided by the total number of days in the program (≥ 70% good, ≥ 80% excellent).

  6. Rates of Ecological Momentary Assessment (EMA) Data [8 Weeks]

    We will assess the feasibility of collecting ecological momentary assessment (EMA) of daily mindfulness practice by calculating the proportion of text-based surveys completed divided by the total number of surveys sent during the program (≥ 70% good, ≥ 80% excellent).

  7. Rates of Treatment Completion [8 Weeks]

    We will assess the acceptability of treatment by calculating the proportion of participants who attend ≥ 6/8 treatment sessions (≥ 70% good, ≥ 80% excellent).

  8. Rates of Therapist Fidelity to Intervention Procedures [8 Weeks]

    We will assess the fidelity of therapists to the intervention procedures by calculating the proportion of sessions with completed audio recordings, progress notes, and checklist with 100% of content delivered divided by the total number of sessions (≥ 75% good, 100% excellent).

  9. Rates of Staff Fidelity to Study Procedures [8 Weeks]

    We will assess the fidelity of staff to the study procedures by counting the frequency of protocol deviations (<5 deviations good, 0 deviations excellent).

  10. Modified Patient Global Impression of Change at 8 weeks [8 Weeks]

    The proportion of participants who report perceived improvements in cognitive function, lifestyle, and emotional well-being outcomes (1=Very Much Worse, 7=Very Much Improved).

  11. Rate of Adverse Events [8 Weeks]

    We will assess the safety of the study by founding the number and severity of adverse events (mild in ≤ 10% of participants = good, none = excellent).

Secondary Outcome Measures

  1. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [0 Weeks, 8 Weeks, 6 Months]

    A comprehensive test of five cognitive domains (immediate memory, visuospatial/constructional, language, attention, and delayed memory) and global cognition. Higher Z and Index Scores indicate greater cognitive functioning on each domain.

  2. Cognitive Function Instrument [0 Weeks, 8 Weeks, 6 Months]

    14-item self-report of cognitive and functional status. Higher total scores (min=0, max=14) indicate greater subjective cognitive complaints.

  3. Change in Step Count [0 Weeks, 8 Weeks, 6 Months]

    Activity watch change in steps count during the 7 days preceding baseline assessment, throughout the intervention period, and 7 days at 6-month follow-up. Higher step count totals indicate greater physical activity (walking).

  4. PROMIS Physical Function [0 Weeks, 8 Weeks, 6 Months]

    8-item self-report of daily functioning. Higher T scores (mean = 50, sd = 10) indicate greater physical function.

  5. Change in Total Sleep Time [0 Weeks, 8 Weeks, 6 Months]

    Activity watch change in total sleep time during the 7 days preceding baseline assessment, throughout the intervention period, and 7 days at 6-month follow-up. Higher total minutes indicate greater sleep time.

  6. Pittsburgh Sleep Quality Index [0 Weeks, 8 Weeks, 6 Months]

    9-item self-report of sleep patterns and overall quality. Higher total scores (min=0, max=21) indicate greater sleep disturbance (>4 = clinically significant).

  7. Mediterranean Eating Pattern for Americans Screener [0 Weeks, 8 Weeks, 6 Months]

    16-item self-report of adherence to Mediterranean dietary recommendations. Higher total scores (min=0, max=21) indicate greater intake/adherence of Mediterranean foods.

  8. PROMIS Alcohol Use [0 Weeks, 8 Weeks, 6 Months]

    7-item self-report of at-risk drinking. Higher T scores (mean = 50, sd = 10) indicate greater problematic alcohol use.

  9. CDC Other Tobacco Product Use Questions [0 Weeks, 8 Weeks, 6 Months]

    2-item self-report of the frequency and use of 6 common tobacco products (1=Less than once a month, 5=Daily or almost daily).

  10. PROMIS Satisfaction with Social Roles and Activities [0 Weeks, 8 Weeks, 6 Months]

    8-item self-report measure of satisfaction of performing usual social roles and activities. Higher T scores (mean = 50, sd = 10) indicate greater satisfaction with social roles and activities.

Other Outcome Measures

  1. Measure of Cognitive Activities [0 Weeks, 8 Weeks, 6 Months]

    10-item self-report measure of frequency of certain cognitive activities (e.g. reading newspapers, playing music, etc). Higher total scores (min=0, max=10) indicate greater participation in cognitively stimulating activities.

  2. Memory Compensation Questionnaire [0 Weeks, 8 Weeks, 6 Months]

    13-item self-report that assesses the variety and extent to which an individual compensates for actual or perceived memory losses. Higher total scores (min=0, max=65) indicate greater utilization of memory compensation strategies.

  3. Godin Leisure-Time Exercise Questionnaire [0 Weeks, 8 Weeks, 6 Months]

    3-item self-report of weekly engagement in light, moderate, and vigorous physical activities. Higher average scores indicate greater engagement in total physical activity.

  4. Social Engagement and Activities Questionnaire [0 Weeks, 8 Weeks, 6 Months]

    10-item self-report measure of perceived frequency of specific social activities. Higher total scores (min=0, max=50) indicate greater participation in socially engaging activities.

  5. PROMIS Loneliness [0 Weeks, 8 Weeks, 6 Months]

    5-item self-report of perceived loneliness. Higher T scores (mean = 50, sd = 10) indicate greater perceived loneliness.

  6. PROMIS Depression and Anxiety [0 Weeks, 8 Weeks, 6 Months]

    4-item self-reports of each construct. Higher T scores (mean = 50, sd = 10) indicate greater depression and anxiety.

  7. Applied Mindfulness Process Scale [0 Weeks, 8 Weeks, 6 Months]

    15-item self-report of using basic mindfulness principles. Higher total scores (min=0, max=60) indicate greater utilization in daily mindfulness activities.

  8. Cognitive Control and Flexibility Questionnaire [0 Weeks, 8 Weeks, 6 Months]

    13-item self-report of control over unwanted experiences. Higher total scores (min=13, max=52) indicate greater daily utilization of cognitive control and flexibility.

  9. Emotion Regulation Questionnaire [0 Weeks, 8 Weeks, 6 Months]

    10-item self-report of emotion regulation strategies. Higher total scores (min=10, max=70) indicate greater utilization of emotional regulation strategies.

  10. Motivation to Change Lifestyle and Health Behaviours for Dementia Risk Reduction [0 Weeks, 8 Weeks, 6 Months]

    27-item self report of motivation and perceived self-efficacy of lifestyle and health behavior change for dementia risk reduction. Higher total scores (min=27, max=135) indicate greater motivation to alter lifestyle factors and health behaviors to reduce risk of dementia.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Concerns about memory or thinking (subjective cognitive decline, SCD)

  • Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) ≥ 6

  • Telephone Interview for Cognitive Status ≥ 28

  • Functional Assessment Questionnaire < 9

  • English fluency/literacy

  • Ability and willingness to participate via live video

  • Clearance by medical doctor for study participation

Exclusion Criteria:
  • Mild cognitive impairment, dementia, or neurodegenerative disease

  • Psychotropic medications (e.g., antidepressant) change in the last 3 months

  • Psychosis, uncontrolled bipolar disorder or substance dependence

  • Current self-report of suicidal ideation

  • Serious medical illness expected to worsen in 6 months (e.g., cancer)

  • Use of digital monitoring device (e.g., Fitbit) in the last 3 moths

  • New mindfulness practice (> 45 min/wk) or cognitive-behavioral therapy in the last 3 months

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ryan A., Mace, PHD, Staff Psychologist, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT05934136
Other Study ID Numbers:
  • 2020P004087
First Posted:
Jul 6, 2023
Last Update Posted:
Jul 6, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2023